1, 4-Dihydropyridine: a dependable heterocyclic ring with the promising and the most anticipable therapeutic effects

AP Mishra, A Bajpai, AK Rai - Mini reviews in medicinal …, 2019 - ingentaconnect.com
Nowadays, heterocyclic compounds act as a scaffold and are the backbone of medicinal
chemistry. Among all of the heterocyclic scaffolds, 1, 4-Dihydropyridine (1, 4-DHP) is one of …

Calcium antagonists and atherosclerosis protection in hypertension

RH Hernández, MJ Armas-Hernández… - American journal of …, 2003 - journals.lww.com
Calcium antagonists are effective in hypertensive patients of all ethnic groups, irrespective of
age, dietary salt intake, salt-sensitivity status or plasma renin activity profile. Some …

SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization

EB Basalious, N Shawky, SM Badr-Eldin - International journal of …, 2010 - Elsevier
The aim of this study was to develop and optimize SNEDDS formulations containing
surfactants reported to be bioenhancers for improvement of dissolution and oral absorption …

Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: formulation optimization, ex vivo and in vivo characterization

R Gannu, CR Palem, VV Yamsani, SK Yamsani… - International journal of …, 2010 - Elsevier
The purpose of the present study was to develop and optimize the microemulsion based
transdermal therapeutic system for lacidipine (LCDP), a poorly water soluble and low …

Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: in-vitro characterization and in-vivo activity

M Qumbar, SS Imam, J Ali, J Ahmad, A Ali - Biomedicine & …, 2017 - Elsevier
The aim of the present research work is to formulate lacidipine (LAC) loaded niosomes
formulation for the management of hypertension by thin film hydration technique. The …

Screening and identification of Lassa virus entry inhibitors from an FDA-approved drug library

P Wang, Y Liu, G Zhang, S Wang, J Guo, J Cao… - Journal of …, 2018 - Am Soc Microbiol
Lassa virus (LASV) belongs to the Mammarenavirus genus (family Arenaviridae) and
causes severe hemorrhagic fever in humans. At present, there are no Food and Drug …

Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 23 factorial design and in vivo evaluation in rabbits

SM Soliman, NS Abdelmalak, ON El-Gazayerly… - Drug …, 2016 - Taylor & Francis
Context: Proniosomes offer a versatile vesicle drug delivery concept with potential for
delivery of drugs via transdermal route. Objectives: To develop proniosomal gel using …

Lacidipine amorphous solid dispersion based on hot melt extrusion: good miscibility, enhanced dissolution, and favorable stability

L Xi, H Song, Y Wang, H Gao, Q Fu - AAPS PharmSciTech, 2018 - Springer
The present study aimed to increase the in vitro dissolution rate of lacidipine, a poorly water-
soluble drug, by formulating amorphous solid dispersions (ASDs) using hot-melt extrusion …

[HTML][HTML] Accelerated repurposing and drug development of pulmonary hypertension therapies for COVID-19 treatment using an AI-integrated biosimulation platform

K Chakravarty, VG Antontsev, M Khotimchenko… - Molecules, 2021 - mdpi.com
The COVID-19 pandemic has reached over 100 million worldwide. Due to the multi-targeted
nature of the virus, it is clear that drugs providing anti-COVID-19 effects need to be …

[HTML][HTML] The calcium channel inhibitor lacidipine inhibits Zika virus replication in neural progenitor cells

B Bezemer, KWR van Cleef, GJ Overheul, P Miesen… - Antiviral Research, 2022 - Elsevier
After decades of being considered non-pathogenic, Zika virus (ZIKV) emerged as an
important threat to human health during the epidemic of 2015–2016. ZIKV infections are …